Sale of Product Line - Narrative (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Mar. 31, 2024	Dec. 31, 2025	Dec. 31, 2024
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from the sale of product line			$ 1,294	$ 5,440
Gain on sale of product line				7,580
Disposal Group, Disposed of by Sale, Not Discontinued Operations | MiMedx Group, Inc.
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from the sale of product line	$ 5,000
Transaction | MiMedx Group, Inc.
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Variable consideration			0	$ 0
Amount minimum revenue share payments receivable	3,000	$ 3,000
Amount minimum revenue share payments receivable current			1,600
Transaction | Minimum | MiMedx Group, Inc.
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenue sharing payments	3,000	3,000
Variable consideration	3,000	3,000
Transaction | Maximum | MiMedx Group, Inc.
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenue sharing payments	7,000	7,000
Variable consideration	7,000	7,000
Transaction | Disposal Group, Disposed of by Sale, Not Discontinued Operations | MiMedx Group, Inc.
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net carrying value	800	800
Carrying value	0	0
Consideration received for inventory on-hand	400
Consideration determined	$ 8,400	8,400
Gain on sale of product line		$ 7,600
Revenue share payments collected			$ 1,400